Literature DB >> 1922078

Coordinate estrogen-regulated instability of serum protein-coding messenger RNAs in Xenopus laevis.

R L Pastori1, J E Moskaitis, S W Buzek, D R Schoenberg.   

Abstract

Estrogen causes the cytoplasmic destabilization of albumin and gamma-fibrinogen mRNA in Xenopus laevis liver. The purpose of the present study was to determine whether mRNA destabilization is a generalized phenomenon in response to estrogen, or whether this process is restricted to a particular class of mRNAs. To address this, we have expanded our bank of serum protein-coding cDNA clones to include transferrin, the second protein of inter-alpha-trypsin inhibitor and clone 12B, for which there is no mammalian homolog. Together with albumin and gamma-fibrinogen, these represent more than 85% of the mRNAs encoding liver secreted proteins. Estrogen administration to male Xenopus or to liver explant cultures causes the generalized disappearance of all of these mRNAs. In contrast, estrogen has no effect on actin, ferritin, or poly(A)-binding protein mRNA, all of which encode intracellular proteins. We have previously demonstrated that albumin mRNA is degraded in both messenger ribonucleoprotein and polysome fractions. Sucrose gradient analysis demonstrates the same pattern for degradation of all other serum protein-coding mRNAs. Estrogen has no effect on the amounts or gradient distribution of actin, ferritin, or poly(A)-binding protein mRNA. We conclude that regulated destabilization of mRNAs encoding secreted proteins is a generalized phenomenon in response to estrogen stimulation of Xenopus liver.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922078     DOI: 10.1210/mend-5-4-461

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  22 in total

1.  Identification of in vivo mRNA decay intermediates corresponding to sites of in vitro cleavage by polysomal ribonuclease 1.

Authors:  M N Hanson; D R Schoenberg
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

2.  Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1.

Authors:  K S Cunningham; R E Dodson; M A Nagel; D J Shapiro; D R Schoenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

3.  Purifying mRNAs with a high-affinity eIF4E mutant identifies the short 3' poly(A) end phenotype.

Authors:  Youkyung Hwang Choi; Curt H Hagedorn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

4.  An endonuclease activity similar to Xenopus PMR1 catalyzes the degradation of normal and nonsense-containing human beta-globin mRNA in erythroid cells.

Authors:  Kirsten A Bremer; Audrey Stevens; Daniel R Schoenberg
Journal:  RNA       Date:  2003-09       Impact factor: 4.942

Review 5.  Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism.

Authors:  Rafal Tomecki; Andrzej Dziembowski
Journal:  RNA       Date:  2010-07-30       Impact factor: 4.942

6.  Under the Tucson sun: a meeting in the desert on mRNA decay.

Authors:  Kristian E Baker; Ciarán Condon
Journal:  RNA       Date:  2004-11       Impact factor: 4.942

7.  c-Src activates endonuclease-mediated mRNA decay.

Authors:  Yong Peng; Daniel R Schoenberg
Journal:  Mol Cell       Date:  2007-03-09       Impact factor: 17.970

8.  Identification of two cis-acting elements that independently regulate the length of poly(A) on Xenopus albumin pre-mRNA.

Authors:  J Das Gupta; H Gu; E Chernokalskaya; X Gao; D R Schoenberg
Journal:  RNA       Date:  1998-07       Impact factor: 4.942

9.  Regulated nuclear polyadenylation of Xenopus albumin pre-mRNA.

Authors:  M N Rao; E Chernokalskaya; D R Schoenberg
Journal:  Nucleic Acids Res       Date:  1996-10-15       Impact factor: 16.971

10.  Cleavage properties of an estrogen-regulated polysomal ribonuclease involved in the destabilization of albumin mRNA.

Authors:  E Chernokalskaya; R Dompenciel; D R Schoenberg
Journal:  Nucleic Acids Res       Date:  1997-02-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.